Amgen Tour of California Women’s Race Overall Start and Second Stage
2017 Amgen Tour of California returns to Lake Tahoe for the Women's Race Overall Start and Second Stage, May 11-12, 2017.
Amgen Tour of California, presented by AEG, the world’s leading sports and live entertainment company, announced that professional cycling will return to Lake Tahoe, May 11-12, 2017. The Amgen Breakaway from Heart Disease Women’s Race Empowered with SRAM will include the overall start and Stage 2 on consecutive days. The women’s competition will conclude with the third stage in Elk Grove, May 13 and the final in Sacramento, May 14.
The women will start with one of the most beautiful race routes in the USA, circumnavigating the 72-mile shoreline of Lake Tahoe with the final climb that will lead riders to the finish at Heavenly Mountain Resort. A new Stage 2 route will be announced early 2017 where riders will face summits in excess of 7,300-feet leading to what promises to be a climatic finish. The upcoming race marks the tenth consecutive year that a women’s competition is a major component of the Amgen Tour of California.
“After the 2016 summer Olympic Games women’s cycling reached a new level and watching these elite athletes here in our backyard lends a new level of appreciation,” said Carol Chaplin, President & CEO of the Lake Tahoe Visitors Authority. “Tahoe South and our partners look forward to celebrating Tahoe as a cycling mecca for top competitors as well as recreational enthusiasts.”
The Amgen Tour of California men’s 600-mile competition is set to begin in Sacramento, May 14, 2017, and will conclude in Pasadena, May 20. The 2017 race will mark the first year the men’s race has been elevated to Union Cycliste Internationale (UCI) WorldTour status, making it the only stage race in North America to receive this prestigious classification.
Returning to California in 2017 is the 2016 Amgen Breakaway From Heart Disease Women’s Race Empowered with SRAM defending Champion and current UCI Women’s World Tour Champion Megan Guarnier racing for the Boels–Dolmans team.
“The Amgen Tour of California has been a superb addition to the Women’s World Tour calendar,” said Guarnier. “As an American, I feel so fortunate to have the opportunity to race at the highest level on American soil. The Amgen Breakaway From Heart Disease Women’s Race Empowered with SRAM allows create the most professional platform to showcase women’s racing alongside the long-running men’s race, and the organization ensures that there is media coverage surrounding the event further elevating the exposure of our event for our current, and I dare say our future, fan base.